Amgen Inc.
391.27USD
-1.9000 (-0.48%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $5.78▲ | $5.76 | 13 | 10 |
| Next quarter | $5.8▼ | $5.88 | 11 | 12 |
| Current year | $23.04▲ | $22.41 | 32 | 0 |
| Next year | $24.4▲ | $23.48 | 28 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $5.62 | $6.29 | +0.67 (+12.0%) |
| 2026-03-31 | $4.77 | $5.15 | +0.38 (+8.0%) |
| 2025-12-31 | $4.73 | $5.29 | +0.56 (+11.9%) |
| 2025-09-30 | $5.01 | $5.64 | +0.63 (+12.5%) |
421 ratings from 43 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BMO Capital | Downgraded from Outperform | Market Perform | $450 | Sep 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $400 | Sep 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $400 $435 | Sep 4, 2026 |
| Piper Sandler | Maintained | Overweight | $427 $457 | Aug 20, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $351 $362 | Aug 19, 2026 |
| Argus Research | Maintained | Buy | $375 $460 | Aug 19, 2026 |
| Mizuho | Maintained | Neutral | $303 $352 | Aug 18, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $350 $400 | Aug 18, 2026 |
| Barclays | Maintained | Equal-Weight | $360 $380 | Aug 14, 2026 |
| Guggenheim | Maintained | Neutral | $343 $388 | Aug 10, 2026 |
| Citigroup | Maintained | Neutral | $345 $405 | Aug 7, 2026 |
| Bernstein | Maintained | Market Perform | $335 $345 | Aug 6, 2026 |
| Baird | Maintained | Underperform | $215 $230 | Aug 5, 2026 |
| Canaccord Genuity | Maintained | Hold | $366 $384 | Aug 5, 2026 |
| B of A Securities | Maintained | Underperform | $312 $317 | Aug 5, 2026 |
| Goldman Sachs | Maintained | Buy | $427 $450 | Aug 5, 2026 |
| UBS | Maintained | Buy | $420 $440 | Aug 5, 2026 |
| TD Cowen | Maintained | Buy | $420 $452 | Aug 5, 2026 |
| Truist Securities | Maintained | Hold | $340 $362 | Aug 5, 2026 |
| Oppenheimer | Maintained | Outperform | $400 $450 | Aug 5, 2026 |
| Scotiabank | Maintained | Sector Outperform | $385 $450 | Aug 5, 2026 |
| RBC Capital | Maintained | Outperform | $370 $400 | Aug 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $390 $400 | Aug 5, 2026 |
| BMO Capital | Maintained | Outperform | $400 $450 | Aug 5, 2026 |
| Barclays | Maintained | Equal-Weight | $350 $360 | Jul 29, 2026 |
114 filings from 22 insiders · 32 buy / 4 sell over 6m
Officers and directors of AMGN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KHOSLA RACHNAOfficer | Exercise | 1.3k | $162.60 | $204k | Aug 13, 2026 |
| KHOSLA RACHNAOfficer | Sell | 3.3k | $412.57 | $1.35M | Aug 13, 2026 |
| ISHRAK OMAR SYEDDirector | Grant | 85 | — | — | Aug 7, 2026 |
| DRAKE MICHAEL VDirector | Grant | 63 | — | — | Aug 7, 2026 |
| BUSCH MATTHEW C.Officer | Grant | 730 | — | — | Aug 7, 2026 |
| HOLLEY CHARLES M JRDirector | Grant | 103 | — | — | Aug 7, 2026 |
| GRYGIEL NANCY AOfficer | Exercise | 3.0k | $177.31 | $527k | Aug 6, 2026 |
| MILLER DEREKOfficer | Exercise | 3.9k | $162.60 | $660k | Aug 6, 2026 |
| GRYGIEL NANCY AOfficer | Sell | 3.0k | $402.16 | $1.19M | Aug 6, 2026 |
| MILLER DEREKOfficer | Sell | 3.9k | $402.54 | $1.57M | Aug 6, 2026 |
| AUSTIN WANDA MDirector | Grant | 665 | — | — | May 19, 2026 |
| DRUKER BRIAN JDirector | Grant | 665 | — | — | May 19, 2026 |
| ISHRAK OMAR SYEDDirector | Grant | 665 | — | — | May 19, 2026 |
| DRAKE MICHAEL VDirector | Grant | 665 | — | — | May 19, 2026 |
| KLOTMAN MARY EDirector | Grant | 665 | — | — | May 19, 2026 |
| HOLLEY CHARLES M JRDirector | Grant | 665 | — | — | May 19, 2026 |
| ECKERT ROBERT ANDREWDirector | Grant | 665 | — | — | May 19, 2026 |
| MILES AMY EDirector | Grant | 665 | — | — | May 19, 2026 |
| KULLMAN ELLEN JAMISONDirector | Grant | 665 | — | — | May 19, 2026 |
| GARLAND GREGORY C.Director | Grant | 665 | — | — | May 19, 2026 |
No analyst notes on AMGN yet.
Analyst Ratings
29 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 9 | 17 | 2 | 2 | Hold2.68 |
| 1 mo ago | 4 | 10 | 16 | 2 | 2 | Hold2.65 |
| 2 mo ago | 4 | 10 | 17 | 2 | 1 | Hold2.59 |
| 3 mo ago | 4 | 10 | 17 | 2 | 1 | Hold2.59 |